₹92
▲ +1.95 +2.17%
As of 21 Oct 2026 · delayed
NSE Listed
Sotac Pharmaceuticals Ltd. (SOTAC)
Volume: 1,200Avg Vol 1W: 480Avg Vol 1M: 12052W Range:₹86₹139.65
Key Ratios
Checked 4h agoMarket Cap₹102 Cr
Current Price₹92
Previous Close₹90.05
High / Low (52w)₹139.65 / ₹86
Volume1,200
Avg Vol (1W)480
Avg Vol (1M)120
Stock P/E17.97
Book Value₹53.28
Dividend Yield22%
ROE9.79%
ROA360.1%
Revenue (TTM)₹102 Cr
Revenue Growth-6.6%
Profit Margin424.7%
Total Debt₹14 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹5.12
P/B1.73
Debt / Equity0.73
50 DMA₹91.19
200 DMA₹106.72
Day change+2.17%
Price Chart
₹92▼ 28.13% · 1Y
2025-10-282026-10-21
20-day avg volume: 120 shares
Pros
- Pays a dividend yield of 22.0%.
- Company is almost debt-free.
Cons
- Revenue fell 41% YoY.
Quarterly Results
| Metric | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹40 Cr | ₹20 Cr | ₹18 Cr | ₹25 Cr | ₹27 Cr | ₹26 Cr | ₹26 Cr | ₹25 Cr |
| EBITDA | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr |
| Net Profit | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Mar 2024 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹19 Cr | ₹14 Cr | ₹18 Cr | ₹104 Cr | ₹16 Cr | ₹13 Cr | ₹101 Cr | ₹102 Cr |
| EBITDA | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹6 Cr | ₹2 Cr | ₹2 Cr | ₹14 Cr | ₹13 Cr |
| Net Profit | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹4 Cr | ₹1 Cr | ₹1 Cr | ₹8 Cr | ₹6 Cr |
| EPS | — | — | — | 3.9 | — | — | 7.26 | 5.22 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Total Assets | ₹30 Cr | ₹35 Cr | ₹74 Cr | ₹105 Cr | ₹124 Cr | ₹133 Cr |
| Total Liabilities | ₹26 Cr | ₹32 Cr | ₹54 Cr | ₹56 Cr | ₹66 Cr | ₹69 Cr |
| Equity | ₹5 Cr | ₹3 Cr | ₹20 Cr | ₹49 Cr | ₹58 Cr | ₹65 Cr |
| Total Debt | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2020 | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹10 Cr | ₹-14 Cr | ₹-4 Cr | ₹19 Cr |
| Investing | ₹-12 Cr | ₹-3 Cr | ₹-12 Cr | ₹-20 Cr | ₹-14 Cr | ₹-7 Cr |
| Financing | ₹11 Cr | ₹3 Cr | ₹13 Cr | ₹29 Cr | ₹16 Cr | ₹-10 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹10 Cr | ₹-14 Cr | ₹-4 Cr | ₹19 Cr |
Shareholding
Promoter 72.85% Institutions 16.79% Public 10.36%
Efficiency & Working Capital
ROCE13.3%
Interest Coverage3.1
Dividend Payout—
Debtor Days119 d
Inventory Days98 d
Payable Days98 d
Cash Conversion Cycle118 d
Working Capital Days216 d
Shareholding Details
As of 2026-03-31
Promoter72.9%
FII16.8%
DII0%
Institutions16.8%
Public10.4%
Promoter Pledge0%
No. of Shareholders221
Shareholding Pattern
Quarterly — figures in %. Latest 8 quarters.
| Period | Apr 2023 | Apr 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% | 72.9% |
| FIIs | 12.9% | 12.9% | 8.5% | 9% | 8.9% | 15.1% | 16.1% | 16.8% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 14.3% | 14.3% | 18.6% | 18.2% | 18.3% | 12% | 11% | 10.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 784 | 784 | 255 | 245 | 251 | 243 | 240 | 221 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Kiran Baldevbhai Jotania | Shareholding of Promoter and Promoter Group | 13.1% | 14,49,000 |
| Vishalkumar Devrajbhai Patel | Shareholding of Promoter and Promoter Group | 13% | 14,31,500 |
| Dineshkumar Babulal Gelot | Shareholding of Promoter and Promoter Group | 13% | 14,31,500 |
| Sharadkumar Dashrathbhai Patel | Shareholding of Promoter and Promoter Group | 13% | 14,31,500 |
| Chetankumar Bachubhai Patel | Shareholding of Promoter and Promoter Group | 9.7% | 10,69,250 |
| Nav Capital Vcc - Nav Capital Emerging Star Fund | Public Shareholding | 7.4% | 8,12,400 |
| Shaileshkumar Vishnuprasad Patel | Shareholding of Promoter and Promoter Group | 7.3% | 8,05,000 |
| Craft Emerging Market Fund Pcc- Elite Capital Fund | Public Shareholding | 7.1% | 7,87,200 |
| Mitul Shaileshkumar Patel | Shareholding of Promoter and Promoter Group | 3.3% | 3,62,250 |
| Minerva Ventures Fund | Public Shareholding | 1.6% | 1,81,200 |
| Kashyapkumar Rajendrakumar Mehta | Public Shareholding | 1.5% | 1,70,400 |
| Walpar Nutritions Limited | Public Shareholding | 1.5% | 1,64,400 |
| Pinki Sharadkumar Patel | Shareholding of Promoter and Promoter Group | 0.2% | 17,500 |
| Dhara Chetankumar Patel | Shareholding of Promoter and Promoter Group | 0.2% | 17,500 |
| Vasantkumar Devrajbhai Patel | Shareholding of Promoter and Promoter Group | 0.2% | 17,500 |
| Sarojben Dineshkumar Gelot | Shareholding of Promoter and Promoter Group | 0.2% | 17,500 |
| Dashrathbhai Ramabhai Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Narmadaben Dashrathbhainpatel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sanjay Dashrathbhai Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dipikaben Nileshkumar Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rekhaben Saileshkumar Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bhavanaben Manishkumarnpatel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aarav Sharadkumar Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Krishna Sharadkumar Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Manubhai Sakalchand Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sharadkumar Dashrathbhai Patel | Chairman & Managing Director | 2025 |
| Dineshkumar Babulal Gelot | Whole-time Director | 2025 |
| Vishalkumar Devrajbhai Patel | Executive Director | 2025 |
| Chetankumar Bachubhai Patel | Executive Director | 2025 |
| Bhavinkumar Prafulbhai Joshi | Independent Non Exe. Director | 2025 |
| Ketankumar Arvindbhai Modi | Independent Non Exe. Director | 2025 |
| Dimpal Dhebarbhai Pate | Independent Non Exe. Director | 2025 |
| Niyati Dipesh Parikh | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 12 | 11 | 11 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-09-23 | Dividend | — |
| dividend | 2026-09-23 | ₹0.2 (2%) | Final |
| dividend | 2025-09-19 | ₹0.1 (1%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 1 | 45 | 46 |
| 2025 | 0 | 0 | 0 | 0 | 26 | 26 |
| 2025 | 0 | 0 | 0 | 1 | 1 | 2 |
Company Information
Incorporated2015
ChairmanSharadkumar Dashrathbhai Patel
AuditorKeyur Shah & Co
Investor Email[email protected]
📍 Plot No PF-21 Nr ACME Pharma, Opp Teva Pharma Sanand GIDC-II, Ahmedabad, Gujarat, 382110
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Sona BLW Precision Frgs LimitedSonal Mercantile Ltd.Sona Machinery LimitedSonam LimitedSonata Software Ltd.Sonu Infratech LimitedSavita Oil Technologies Ltd.South Indian BankSouth West Pinnacle Exploration Ltd.SP Apparels LimitedSpandana Sphoorty Financial Ltd.Sun Pharma Advanced Research Company Ltd.All “S” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search